Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

#865 of 11K

J1426

Casimersen (Amondys 45) injection, 10 mg

Casimersen (Amondys 45) injection, 10 mg is the #865 most-billed Medicaid procedure code, with $65.6M in payments across 2K claims from 2018–2024. The national median cost per claim is $31,833.01.

Total Paid

$65.6M

0.01% of all spending

Total Claims

2K

Providers

1

Avg Cost/Claim

$32K

National Cost Distribution

How much do providers bill per claim for J1426? Based on 1 providers billing this code nationally.

Median

$31,833.01

Average

$31,833.01

Std Dev

Max

$31,833.01

Percentile Distribution (Cost per Claim)

p10
$31,833.01
p25
$31,833.01
Median
$31,833.01
p75
$31,833.01
p90
$31,833.01
p95
$31,833.01
p99
$31,833.01

50% of providers bill between $31,833.01 and $31,833.01 per claim for this code.

90% bill between $31,833.01 and $31,833.01.

Top 1% bill above $31,833.01.

About This Procedure

HCPCS code J1426 (Casimersen (Amondys 45) injection, 10 mg) was billed by 1 providers across 2K claims, totaling $65.6M in Medicaid payments from 2018–2024. This code was used for 747 unique beneficiaries.

Fraud Risk Context

Injectable drug codes carry high per-claim costs and have been involved in drug diversion and upcoding schemes.

Source: HHS OIG Reports

Risk Assessment

Billing Statistics

Median Cost/Claim

$31,833.01

Providers Billing

1

National Spending

$65.6M

Avg/Median Ratio

1.00×

Normal distribution

Provider Coverage

We have 1 providers billing this code in our dataset. Individual provider breakdowns are available for top-spending procedure codes.